Reckitt Benckiser Would Look at Buying Pfizer Consumer Unit

  • CEO Kapoor says he'd be `very interested' given opportunity
  • Division would be good acquisition option, Exane analysts say

Reckitt Benckiser Group Plc would consider acquiring Pfizer Inc.’s consumer-health unit were it to come up for sale in the wake of the Viagra maker’s merger with Allergan Plc.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.